InvestorsHub Logo
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

Re: None

Saturday, 02/02/2008 9:00:06 AM

Saturday, February 02, 2008 9:00:06 AM

Post# of 746
Wachovia 2008 Healthcare Conference

Not much new from the earlier conference. Some brief points (all 191 related):
1-Dr. Porter made a passing remark that could be taken that 191 BID dosing went well (something to the effect of better dosing then other PI's)
2-4th cohort may be done based on safety/tolerability.
3-Q2 still plan for starting combination trial
4-On track to release data from first 3 cohorts around end of quarter
5-Said Roche can and will design studies with all combinations of anti-virals in their portfolio. Hinted at doing this particular in the true non-responders.